Jeffrey A Cohen
Title
Cited by
Cited by
Year
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
87892011
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ...
Annals of Neurology: Official Journal of the American Neurological …, 2005
59582005
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina, C Von Kalle, M Schmidt, MP McCormack, ...
science 302 (5644), 415-419, 2003
40102003
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision …
Age-Related Eye Disease Study Research Group
Archives of ophthalmology 119 (10), 1417-1436, 2001
3256*2001
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
24572018
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
23902010
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis: results of a phase III multicenter, double‐blind, placebo‐controlled trial
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 45 (7), 1268-1276, 1995
22991995
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
21432014
Fatigue in multiple sclerosis
LB Krupp, N McLinskey, WS MacAllister
Multiple Sclerosis Therapeutics, 805-818, 2007
10912007
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ...
The lancet 380 (9856), 1829-1839, 2012
9612012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ...
The Lancet 380 (9856), 1819-1828, 2012
9562012
Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics
MC Raff, ER Abney, J Cohen, R Lindsay, M Noble
Journal of Neuroscience 3 (6), 1289-1300, 1983
8491983
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.
V Dousset, RI Grossman, KN Ramer, MD Schnall, LH Young, ...
Radiology 182 (2), 483-491, 1992
7831992
Differential diagnosis of suspected multiple sclerosis: a consensus approach
DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ...
Multiple Sclerosis Journal 14 (9), 1157-1174, 2008
7662008
Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.
BT Shahani, JJ Halperin, PH Boulu, J Cohen
Journal of Neurology, Neurosurgery & Psychiatry 47 (5), 536-542, 1984
7391984
Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic …
V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ...
Pm&r 3 (4), 345-352. e21, 2011
7162011
Post-traumatic stress disorder
A Shalev, I Liberzon, C Marmar
New England Journal of Medicine 376 (25), 2459-2469, 2017
669*2017
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 50 (3), 701-708, 1998
6391998
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
DB Weiner, J Liu, JA Cohen, WV Williams, MI Greene
Nature 339 (6221), 230-231, 1989
5471989
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
MD Goldman, RA Marrie, JA Cohen
Multiple Sclerosis Journal 14 (3), 383-390, 2008
5192008
The system can't perform the operation now. Try again later.
Articles 1–20